|
ALZA Corporation |
||
ALZA: Challenges and Rewards in Drug Delivery
Today, ALZA offers the broadest array of
technology platforms, including oral, transdermal, implantable and
liposomal technologies, and is unmatched in its success in bringing
drug delivery-based products to market.
In 2001, ALZA merged with New Brunswick, NJ-based Johnson &
Johnson, the world’s most comprehensive and broadly based
manufacturer of healthcare products, as well as provider of related
services, for the consumer, pharmaceutical and medical devices and
diagnostics markets. As a
result of the merger, ALZA continues as an independent operating
company, focusing on the development and manufacture of pharmaceutical
products based on novel drug delivery technology solutions for Johnson
& Johnson and other companies in the global pharmaceutical
industry. Streamlining Efforts with Johnson & JohnsonDrug makers covet delivery technologies that companies such
as ALZA develop because they can often significantly enhance
medications and potentially provide an extension on the patent life of
a drug. However, success
at ALZA is not measured simply by gaining regulatory approval of a
Phase III product. Rather,
the main objective has always been launching high-quality product into
the market, where patients will benefit from its therapeutic
advantages. ALZA alone is expected to add $700 million in sales to J&J’s annual pharmaceutical sales of roughly $14.5 billion in 2002. Additionally, in joining the Johnson & Johnson family of companies, ALZA has access to one of the world’s largest R&D networks, which is advantageous to both ALZA and its partners, presenting a greater opportunity for technological advances. What
Sets ALZA Apart Many of the world’s leading pharmaceutical companies have worked with ALZA in the application of its delivery technologies for the development of drugs with enhanced therapeutic value for patients. ALZA’s technologies are now incorporated in more than 30 products marketed by its pharmaceutical partners in over 80 countries around the world. |
technologies as their base, ALZA pioneered
pharmacologic discovery by seeking the best ways to delivery compounds
– the ideal pattern and site of delivery – thereby optimizing the
pharmacology to add significant value to a chemical.
By optimizing the pharmacology of a drug, ALZA can optimize the
effectiveness of a compound and create a successful product that
benefits patients at the end of the day. Small-company
Environment, Big-company Impact ALZA’s supportive, small-company environment
is driven by leaders who play an integral role in all phases of the
product development process, including analytical sciences,
toxicology, pre-clinical and clinical research, and regulatory
affairs. The community of professionals at ALZA appreciates the sense
of personal impact they have on the bottom line.
For those who desire a team-based environment
that offers opportunities for employee growth and development,
ALZA’s world-class Learning and Development Department provides a
variety of on-site training courses.
ALZA is dedicated to enhancing and recognizing individual and
organizational performance. Delivering Powerful Solutions From nonprofit service providers to educational
institutions and civic organizations, ALZA fulfills community needs as
a team. With the
company’s headquarters in Mountain View, CA, and its manufacturing
facilities in Vacaville, CA and Cashel, Ireland, ALZA continues to
contribute to numerous community improvement efforts in the areas of
culture, education, and health. ALZA’s
organization is based on solution-driven performers who are focused on
improving lives in our community around the world. Explore a team-oriented environment that is leading drug delivery solutions to improve the lives of people worldwide. Visit www.alza.com/careers to learn about specific opportunities at ALZA and working within the Johnson & Johnson Family of Companies. |
|
| ALZA Corporation | ||